Apheresis in thoracic organ transplantation

Therapeutic Apheresis

Volumn 3, Issue 1, 1999, Pages 34-39

  Robinson, John A ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Allograft rejection; Immunosuppression; Thoracic organ transplantation

Indexed keywords

CYCLOPHOSPHAMIDE; HEPARIN; IMMUNOSUPPRESSIVE AGENT;

ADJUVANT THERAPY; ANTICOAGULANT THERAPY; APHERESIS; ARTICLE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; LUNG TRANSPLANTATION; ORAL DRUG ADMINISTRATION; ORGAN TRANSPLANTATION; PLASMAPHERESIS; PRIORITY JOURNAL; THROMBOCYTOPENIA; THROMBOSIS;

ADULT; BLOOD COMPONENT REMOVAL; GRAFT REJECTION; HEART TRANSPLANTATION; HEPARIN; HUMANS; LUNG TRANSPLANTATION; MIDDLE AGED; PHOTOCHEMOTHERAPY; THROMBOCYTOPENIA;

EID: 0032970972     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-0968.1999.00137.x     Document Type: Article

References (15)

1. Smith JD, Dansklee AJ, Laylor RM, Rose ML, Yacoub MH. The effect of panel reactive antibodies and the donor specific crossmatch on graft survival after heart and heart-lung transplantation. Transplant Immunol 1993;1:60-5.
2. Gammie JS, Pham SI, Colson YL, Kawai A, Keenan RJ, Weyant RJ, Griffith BP. Influence of panel-reactive antibody on survival and rejection after lung transplantation. J Heart Lung Transplant 1997;18:408-15.
3. Robinson JA, Radvany RM, Mullen GM, Garrity ER. Plasmapheresis followed by intravenous immunoglobulin in presensitized patients awaiting thoracic organ transplantation. Ther Apheresis 1997;1:147-51.
4. Pisani BA, Mullen GM, Silver MA, Malinowski K, Lawless CE, Mendez J, Barath PC, Robinson JA. Plasmapheresis with intravenous immunoglobulin G is effective in patients with elevated panel reactive antibody prior to cardiac transplantation. J Heart Lung Transplant 1998;17:52A.
5. Tyan DB, Li VA, Czer L, Trento A, Jordan SC. Intravenous immunoglobulin suppression of HLA alloantibody in highly sensitized transplant candidates and transplantation with histoincompatible organ. Transplantation 1994;57:553-7.
6. McIntyre JA, Higgins N, Britton R, Faucett S, Johnson S, Beckman D, Hormuth D, Fehrenbacher J, Halbrook H. Utilization of intravenous immunoglobuhn to ameliorate alloantibodies in a highly sensitized patient with a cardiac assist device awaiting heart transplantation. Fluorescence-activated cell sorter analysis. Transplantation 1996;62(5):691-3.
7. Robinson JA. Plasmapheresis in the management of heparin induced thrombosis. Seminars in hematology. Philadelphia: WB Saunders, 1999 (in press).
8. Hammond EH, Yowell RL, Nunoda S, Menlove RL, Renlund DG, Bristow MR, Gay WA, Jones KW, O'Connell JB. Vascular (humoral) rejection in heart transplantation: Pathologic observations and clinical implications. J Heart Transplant 1989;8:430-43.
9. Malafa M, Mancini MC, Myles JL, Gohara A, Dickinson JM, Walsh TE. Successful treatment of acute humoral rejection in a heart transplant patient. J Heart Lung Transplant 1992;11: 486-91.
10. Partanen J, Nieminen M, Krogerus L, Harjula AL, Mattila S. Heart transplant rejection treated with plasmapheresis. J Heart Lung Transplant 1992;11:301-5.
11. Costanzo-Nordin MR, Hubbell EA, O'Sullivan J, Johnson MR, Mullen M, Heroux A, Kao WG, McManus EM, Pifarre R, Robinson JA. Photopheresis versus corticosteroids in the therapy of heart transplant rejection. Preliminary clinical report. Circulation 1992;86:11-242-50.
12. Barr ML, McLaughlin SN, Murphy MP, Stouch BC, Wiedermann JG, Marboe CC, Schenkel FA, Berger CL, Rose EA. Prophylactic photopheresis and effect on graft atherosclerosis in cardiac transplantation. Transplant Proc 1995;27(3):1993-4.
13. Meiser BM, Kur F, Reichensplurner H, Wagner F, Boos KS, Vielhauer S, Weiss M, Rohrbach H, Kreuzer E, Uberfuhr P. Reduction of the incidence of rejection by adjunct immunosuppression with photochemotherapy after heart transplantation. Transplantation 1994;57(4):563-8.
14. Achlar A, Laaban JP, Couetil JP, Hesmati F, Dore MF, Molina T, Rochemaure J, Andreu G. Extracorporeal photochemotherapy (ECP) for bronchiolitis obliterans (BO) after heart-lung (HLTX) and lung transplantation. J Heart Lung Transplant 1997;16(1):96A.
15. Andreu G, Achkar A, Couetil JP, Guillemain R, Heshmati F, Amrein C, Chevalier P, Guinvarch A, Dore MF, Capron F, Laaban JP, Carpentier A. Extracorporeal photochemotherapy treatment for acute lung rejection episode. J Heart Lung Transplant 1995;14:793-6.